↓ Skip to main content

Tramadol has a Better Potency Ratio Relative to Morphine in Neuropathic than in Nociceptive Pain Models

Overview of attention for article published in Drugs in R&D, October 2012
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age

Mentioned by

wikipedia
8 Wikipedia pages

Citations

dimensions_citation
33 Dimensions

Readers on

mendeley
18 Mendeley
Title
Tramadol has a Better Potency Ratio Relative to Morphine in Neuropathic than in Nociceptive Pain Models
Published in
Drugs in R&D, October 2012
DOI 10.2165/00126839-200708010-00005
Pubmed ID
Authors

Thomas Christoph, Babette Kögel, Wolfgang Strassburger, Stephan A. Schug

Abstract

Treatment of neuropathic pain remains a challenge and the role of various analgesics in this setting is still debated. The effects of tramadol, an atypically acting analgesic with a combined opioid and monoaminergic mechanism of action, and morphine, a prototypical opioid, were tested in rat models of neuropathic and nociceptive pain.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 18 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 18 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 7 39%
Student > Master 3 17%
Student > Ph. D. Student 2 11%
Student > Bachelor 2 11%
Student > Postgraduate 2 11%
Other 1 6%
Unknown 1 6%
Readers by discipline Count As %
Medicine and Dentistry 7 39%
Veterinary Science and Veterinary Medicine 1 6%
Sports and Recreations 1 6%
Biochemistry, Genetics and Molecular Biology 1 6%
Neuroscience 1 6%
Other 1 6%
Unknown 6 33%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 13 July 2023.
All research outputs
#8,535,472
of 25,374,917 outputs
Outputs from Drugs in R&D
#141
of 371 outputs
Outputs of similar age
#67,587
of 202,129 outputs
Outputs of similar age from Drugs in R&D
#47
of 125 outputs
Altmetric has tracked 25,374,917 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 371 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.5. This one is in the 35th percentile – i.e., 35% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 202,129 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 44th percentile – i.e., 44% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 125 others from the same source and published within six weeks on either side of this one. This one is in the 8th percentile – i.e., 8% of its contemporaries scored the same or lower than it.